Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Cilansetron> ?p ?o. }
Showing items 1 to 75 of
75
with 100 items per page.
- Cilansetron abstract "Cilansetron is a drug that is a 5HT-3 antagonist currently under trial phase in the EU and US it is manufactured by Solvay Pharmaceuticals INC.5HT-3 receptors are responsible for causing many things from nausea to excess bowel movements. It is thought in conditions like irritable bowel syndrome (IBS) the receptors have become faulty or oversensitive. 5HT-3 antagonists work by blocking the nervous and chemical signals from reaching these receptors.Studies have shown that the drug can greatly improve quality of life in men and women with diahorrea predominant IBS (1) Cilansetron is the first 5HT antagonist specifically designed for IBS that is effective in men as well as women.(1)Solvay has had considerable difficulty with the medicines regulators in the UK, EU and USA with regards to licensing the drug. This could possibly be due to the problems discovered after licensing with the drug Lotronex. At time of writing; Solvay had recently withdrawn its application to the U.S. Food and Drug Administration (FDA) but was continuing its talks with the MHRA in the UK and EU regulators. (2)It is not currently known what sort of timeframe the public are looking at to be able to obtain the drug. This matter is not helped by the lack of information about cilansetron and its trials in the public domain. The regulators have also stated this in their responses.[citation needed]There is no information about future trials currently available.Some people have tried the Anti-emetic ondansetron HCl (Zofran) as a substitute for the time being, results are mixed but noted effect has been shown in some males and females (3)However; due to its license in the UK it is usually only prescribable at consultant level. Since the licensing of a generic version it is more likely an NHS prescription will be accepted as the branded version is very expensive (Official NHS pricing.) In the USA and Canada: availability often depends on insurance and the doctors personal opinion on off-label prescribing.".
- Cilansetron atcPrefix "A03".
- Cilansetron atcSuffix "AE03".
- Cilansetron bioavailability "87.0".
- Cilansetron casNumber "120635-74-7".
- Cilansetron fdaUniiCode "2J6DQ1U5B5".
- Cilansetron iupacName "(10R)-10-[(2-methyl-1H-imidazol-1-yl)methyl]-5,6,9,10".
- Cilansetron iupacName "-tetrahydro-4H-pyrido(3,2,1-jk)carbazol-11-one".
- Cilansetron pubchem "6918107".
- Cilansetron thumbnail Cilansetron.svg?width=300.
- Cilansetron wikiPageExternalLink j.1365-2036.1996.30172000.x.
- Cilansetron wikiPageExternalLink cilanserton.
- Cilansetron wikiPageExternalLink cilanserton.
- Cilansetron wikiPageExternalLink contact.
- Cilansetron wikiPageID "5753484".
- Cilansetron wikiPageRevisionID "567922485".
- Cilansetron atcPrefix "A03".
- Cilansetron atcSuffix "AE03".
- Cilansetron bioavailability "87.0".
- Cilansetron c "20".
- Cilansetron casNumber "120635".
- Cilansetron chemspiderid "5293321".
- Cilansetron eliminationHalfLife "6840.0".
- Cilansetron excretion "Renal".
- Cilansetron h "21".
- Cilansetron hasPhotoCollection Cilansetron.
- Cilansetron inchi "1".
- Cilansetron inchikey "NCNFDKWULDWJDS-OAHLLOKOBR".
- Cilansetron iupacName "-10".
- Cilansetron iupacName "-tetrahydro-4H-pyridocarbazol-11-one".
- Cilansetron kegg "D03495".
- Cilansetron legalStatus "Unlicensed".
- Cilansetron metabolism "Hepatic".
- Cilansetron molecularWeight "319.4".
- Cilansetron n "3".
- Cilansetron o "1".
- Cilansetron pregnancyCategory "C".
- Cilansetron pubchem "6918107".
- Cilansetron routesOfAdministration "Oral".
- Cilansetron smiles "O=C3c2c1cccc5c1nCCC5".
- Cilansetron stdinchi "1".
- Cilansetron stdinchikey "NCNFDKWULDWJDS-OAHLLOKOSA-N".
- Cilansetron unii "2".
- Cilansetron verifiedrevid "447569820".
- Cilansetron subject Category:5-HT3_antagonists.
- Cilansetron subject Category:Imidazoles.
- Cilansetron subject Category:Ketones.
- Cilansetron subject Category:Nitrogen_heterocycles.
- Cilansetron type Abstraction100002137.
- Cilansetron type Base114618253.
- Cilansetron type Chemical114806838.
- Cilansetron type Compound114818238.
- Cilansetron type Imidazole114916670.
- Cilansetron type Imidazoles.
- Cilansetron type Ketone114926294.
- Cilansetron type Ketones.
- Cilansetron type Material114580897.
- Cilansetron type Matter100020827.
- Cilansetron type OrganicCompound114727670.
- Cilansetron type Part113809207.
- Cilansetron type PhysicalEntity100001930.
- Cilansetron type Relation100031921.
- Cilansetron type Substance100019613.
- Cilansetron type Drug.
- Cilansetron type DrugProduct.
- Cilansetron type FunctionalSubstance.
- Cilansetron comment "Cilansetron is a drug that is a 5HT-3 antagonist currently under trial phase in the EU and US it is manufactured by Solvay Pharmaceuticals INC.5HT-3 receptors are responsible for causing many things from nausea to excess bowel movements. It is thought in conditions like irritable bowel syndrome (IBS) the receptors have become faulty or oversensitive.".
- Cilansetron label "Cilansetron".
- Cilansetron sameAs m.0f2vhr.
- Cilansetron sameAs Q5119931.
- Cilansetron sameAs Q5119931.
- Cilansetron sameAs Cilansetron.
- Cilansetron wasDerivedFrom Cilansetron?oldid=567922485.
- Cilansetron depiction Cilansetron.svg.
- Cilansetron isPrimaryTopicOf Cilansetron.
